{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:07:10Z","timestamp":1759482430681,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>In conjunction with BMJ Case Reports, DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years.<\/jats:p>","DOI":"10.1136\/dtb.2019.228354rep","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T13:24:09Z","timestamp":1564061049000},"page":"125-127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Republished: Complex encephalopathy arising from the combination of opioids and gabapentin"],"prefix":"10.1136","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3529-9781","authenticated-orcid":false,"given":"Harpreet","family":"Singh","sequence":"first","affiliation":[{"name":"Internal Medicine, Allegiance Health, Dexter, Michigan, USA"},{"name":"Michigan State University College of Osteopathic Medicine, East Lansing, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Handa","sequence":"additional","affiliation":[{"name":"Allegiance Health, Jackson, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kak","sequence":"additional","affiliation":[{"name":"Internal Medicine, Allegiance Health, Dexter, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Wasilewski","sequence":"additional","affiliation":[{"name":"Allegiance Health, Jackson, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"2025082700031038000_57.8.125.1","doi-asserted-by":"crossref","unstructured":"Gomes T , Juurlink DN , Antoniou T , et al . Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case\u2013control study. PLoS Med;14:e1002396 http:\/\/journals.plos.org\/plosmedicine\/article?id= doi:10.1371\/journal.pmed.1002396","DOI":"10.1371\/journal.pmed.1002396"},{"key":"2025082700031038000_57.8.125.2","unstructured":"United states food and drug administration (Internet). Database on gabapentin. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020235s041,020882s028,021129s027lbl.pdf."},{"key":"2025082700031038000_57.8.125.3","first-page":"266","article-title":"Gabapentin use in a managed medicaid population","volume":"8","author":"Hamer","year":"2002","journal-title":"J Manag Care Pharm"},{"key":"2025082700031038000_57.8.125.4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11126-016-9421-7","article-title":"Abuse of gabapentin is associated with opioid addiction","volume":"87","author":"Bastiaens","year":"2016","journal-title":"Psychiatr Q"},{"key":"2025082700031038000_57.8.125.5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"2025082700031038000_57.8.125.6","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200007000-00035"},{"key":"2025082700031038000_57.8.125.7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejps.2015.11.015","article-title":"Co-Administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain","volume":"82","author":"Papathanasiou","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"2025082700031038000_57.8.125.8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00325481.2017.1263139","article-title":"Patterns of naloxone use in hospitalized patients","volume":"129","author":"Yung","year":"2017","journal-title":"Postgrad Med"},{"key":"2025082700031038000_57.8.125.9","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015620800"},{"key":"2025082700031038000_57.8.125.10","unstructured":"Singh V , Chukwurah O , Petraglia A , et al . Gabapentin withdrawal causing adrenergic toxidrome. A case report and literature review. pulm CCM J 2015."},{"key":"2025082700031038000_57.8.125.11","article-title":"Intoxications associated with agitation, tachycardia, hypertension, and fever: differential diagnosis, evaluation, and management","volume":"15","author":"Keary","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"2025082700031038000_57.8.125.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00200.x"},{"key":"2025082700031038000_57.8.125.13","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-958522"},{"key":"2025082700031038000_57.8.125.14","doi-asserted-by":"publisher","DOI":"10.1177\/070674370304800211"},{"key":"2025082700031038000_57.8.125.15","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120016965"},{"key":"2025082700031038000_57.8.125.16","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199904000-00019"},{"key":"2025082700031038000_57.8.125.17","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0320a"},{"key":"2025082700031038000_57.8.125.18","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1Q057","article-title":"Akathisia induced by gabapentin withdrawal","volume":"45","author":"See","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2025082700031038000_57.8.125.19","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200505000-00011"},{"key":"2025082700031038000_57.8.125.20","doi-asserted-by":"crossref","unstructured":"Lee YI , Chen L , Smith RL . Enigmatic fever and delirium in a critically ill patient. 12, 2015: 1407\u20139.","DOI":"10.1513\/AnnalsATS.201504-188CC"},{"key":"2025082700031038000_57.8.125.21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/add.13408","article-title":"Misuse of gabapentin and pregabalin: a marker for a more serious malaise?","volume":"111","author":"Stannard","year":"2016","journal-title":"Addiction"},{"key":"2025082700031038000_57.8.125.22","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12420"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2019.228354rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:03:19Z","timestamp":1756278199000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2019.228354rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,25]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/dtb.2019.228354rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2019.228354rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}